Commercialization Strategy for Natural Compounds Based on the Convergence of AI-In Silico and Cell Culture Technologies

PROGRAM

Conference

A platform for exchanging trends and discussions on bioindustry technologies by global scholars and experts.

글보기
Commercialization Strategy for Natural Compounds Based on the Convergence of AI-In Silico and Cell Culture Technologies

글보기
Category	Cell Culture
Date	Sep 10 (Thu) 13:00 ~ 18:00

글보기
Reception period	2026-08-04 ~ 2026-09-08
Venue	Andong Gymnasium Auxiliary Arena

글보기
Chair	Prof. Byung-San Moon(Yeungnam University), Prof. Choon-Young Kim(Yeungnam University), Prof. Ji-Wook Jang(Daegu Haany University)

Upgrading Natural Products and Multifaceted Industrialization Strategies Based on AI-In Silico (AI-IS) Technologies

Director of Research, Institute of Cell Culture, Yeungnam University

Strategy to Build a Hyperscale AI Industry Ecosystem for AX Innovation

Head of Division, Gyeongbuk Institute for IT Convergence Technology

Transition to AI-Driven Data-Based Materials R&D

Director of Research, Insilico Co., Ltd.

Cases of Natural Product Material Discovery Utilizing Pharmaco-Net

CEO, CALICI Co., Ltd.

Multi-Omics AI: Data Integration and AI Architectures

CEO, Medirita Co., Ltd.

Natural Bioactive Compounds for Improving Muscle Function and Metabolic Health: Integrating AI and In Silico Approaches

Prof., Bioactive Natural Compounds for Improving Muscle Function and Metabolic Health: Integration of AI and In Silico Approaches

An Integrated Drug Discovery Strategy Combining AI, In Silico Technologies, and Biological Validation

Director, BNJ Biopharma Co., Ltd.

Development of AI-Based Customized Cell Culture Media Derived from Natural Products

Team Leader, Sempio Foods Co., Ltd.

Panel Discussion

Ik-Jae Moon, Jae-Mun Choi, Myeong-Hee Kim, Ji-Hoe Kim, Dong-Hoon Cho